A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2

Methods in Enzymology

Volumn 477, Issue C, 2010, Pages 109-123

  Anastassiadis, Konstantinos ^a   Glaser, Stefan ^a,b   Kranz, Andrea ^a   Berhardt, Kaj ^a   Stewart, A Francis ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; DRE RECOMBINASE; ESTROGEN RECEPTOR; HYBRID PROTEIN; PROTEIN CREERT2; RECOMBINASE; TAMOXIFEN; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; EXON; GENETIC RECOMBINATION; GENOME; LOXP SITE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; TRANSGENE;

EID: 77955377233     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)77007-5     Document Type: Chapter

References (66)

1. Albert H., Dale E.C., Lee E., Ow D.W. Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J. 1995, 7:649-659.
2. Anastassiadis K., Fu J., Patsch C., Hu S., Weidlich S., Duerschke K., Buchholz F., Edenhofer F., Stewart A.F. Dre recombinase, like Cre, is a highly efficient site specific recombinase in E. coli, mammalian cells and mice. Dis. Model Mech. 2009, 2:508-515.
3. Awatramani R., Soriano P., Rodriguez C., Mai J.J., Dymecki S.M. Cryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation. Nat. Genet. 2003, 35:70-75.
4. Badea T.C., Hua Z.L., Smallwood P.M., Williams J., Rotolo T., Ye X., Nathans J. New mouse lines for the analysis of neuronal morphology using CreER(T)/loxP-directed sparse labeling. PLoS ONE 2009, 16:e7859.
5. Baer A., Bode J. Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. Curr. Opin. Biotechnol. 2001, 12:473-480.
6. Branda C.S., Dymecki S.M. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev. Cell 2004, 6:7-28.
7. Buchholz F., Ringrose L., Angrand P.-O., Rossi F., Stewart A.F. Different thermostabilities of FLP and Cre recombinases: Implications for applied site specific recombination. Nucleic Acids Res. 1996, 24:4256-4262.
8. Buchholz F., Angrand P.-O., Stewart A.F. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat. Biotechnol. 1998, 16:657-662.
9. Casanova E., Fehsenfeld S., Lemberger T., Shimshek D.R., Sprengel R., Mantamadiotis T. ER-based double iCre fusion protein allows partial recombination in forebrain. Genesis 2002, 34:208-214.
10. Chen Y., Rice P.A. New insight into site-specific recombination from FLP recombinase-DNA structures. Annu. Rev. Biophys. Biomol. Struct. 2003, 32:135-159.
11. Copeland N.G., Jenkins N.A., Court D.L. Recombineering: A powerful new tool for mouse functional genomics. Nat. Rev. Genet. 2001, 2:769-779.
12. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 1998, 8:1323-1326.
13. Ennifar E., Meyer J.E., Buchholz F., Stewart A.F., Suck D. Crystal structure of a wild-type Cre recombinase-loxP synapse reveals a novel spacer conformation suggesting an alternative mechanism for DNA cleavage activation. Nucleic Acids Res. 2003, 31:5449-5460.
14. Feil R., Brocard J., Mascrez B., LeMeur M., Metzger D., Chambon P. Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. USA 1996, 93:10887-10890.
15. Feil R., Wagner J., Metzger D., Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun. 1997, 237:752-757.
16. Ghosh K., Guo F., Van Duyne G.D. Synapsis of loxP sites by Cre recombinase. J. Biol. Chem. 2007, 282:24004-24016.
17. Glaser S., Anastassiadis K., Stewart A.F. Current issues in mouse genome engineering. Nat. Genet. 2005, 37:1187-1193.
18. Glaser S., Lubitz S., Loveland K.L., Ohbo K., Robb L., Schwenk F., Seibler J., Röllig D., Kranz A., Anastassiadis K., Stewart A.F. The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly during development and spermatogenesis. Epigenetics Chromatin 2009, 2:5.
19. Grindley N.D., Whiteson K.L., Rice P.A. Mechanisms of site-specific recombination. Annu. Rev. Biochem. 2006, 75:567-605.
20. Hameyer D., Loonstra A., Eshkind L., Schmitt S., Antunes C., Groen A., Bindels E., Jonkers J., Krimpenfort P., Meuwissen R., Rijswijk L., Bex A., Berns A., Bockamp E. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol. Genomics 2007, 31:32-41.
21. Hérault Y., Rassoulzadegan M., Cuzin F., Duboule D. Engineering chromosomes in mice through targeted meiotic recombination (TAMERE). Nat. Genet. 1998, 20:381-384.
22. Higashi A.Y., Ikawa T., Muramatsu M., Economides A.N., Niwa A., Okuda T., Murphy A.J., Rojas J., Heike T., Nakahata T., Kawamoto H., Kita T., et al. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J. Immunol. 2009, 182:5633-5640.
23. Hoess R.H., Wierzbicki A., Abremski K. The role of the loxP spacer region in P1 site-specific recombination. Nucleic Acids Res. 1986, 14:2287-2300.
24. Kaul A., Köster M., Neuhaus H., Braun T. Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice. Cell 2000, 102:17-19.
25. Kellendonk C., Tronche F., Monaghan P.-A., Angrand P.-O., Stewart A.F., Schütz G. Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res. 1996, 24:1404-1411.
26. Kim J.C., Dymecki S.M. Genetic fate-mapping approaches: new means to explore the embryonic origins of the cochlear nucleus. Methods Mol. Biol. 2009, 493:65-85.
27. Kolb A.F. Selection-marker-free modification of the murine beta-casein gene using a lox2272 [correction of lox2722] site. Anal. Biochem. 2001, 290:260-271.
28. Kranz A., Fu J., Duerschke K., Weidlich S., Naumann R., Anastassiadis K., Stewart A.F. An improved Flp deleter mouse in C57Bl/6 based on Flpo recombinase. Genesis 2010, [Epub ahead of print].
29. Kühn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science 1995, 269:1427-1429.
30. Lee G., Saito I. Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. Gene 1998, 216:55-65.
31. Logie C., Stewart A.F. Ligand-regulated site-specific recombination. Proc. Natl. Acad. Sci. USA 1995, 92:5940-5944.
32. Loonstra A., Vooijs M., Beverloo H.B., Allak B.A., van Drunen E., Kanaar R., Berns A., Jonkers J. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl. Acad. Sci. USA 2001, 98:9209-9214.
33. Muyrers J.P., Zhang Y., Testa G., Stewart A.F. Rapid modification of bacterial artificial chromosomes by ET recombination. Nucleic Acids Res. 1999, 27:1555-1557.
34. Nagy A., Moens C., Ivanyi E., Pawling J., Gertsenstein M., Hadjantonakis A.K., Pirity M., Rossant J. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr. Biol. 1998, 8:661-664.
35. Naiche L.A., Papaioannou V.E. Cre activity causes widespread apoptosis and lethal anemia during embryonic development. Genesis 2007, 45:768-775.
36. Pettitt S.J., Liang Q., Rairdan X.Y., Moran J.L., Prosser H.M., Beier D.R., Lloyd K.C., Bradley A., Skarnes W.C. Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat. Methods 2009, 6:493-495.
37. Rajewsky K., Gu H., Kühn R., Betz U.A., Müller W., Roes J., Schwenk F. Conditional gene targeting. J. Clin. Invest. 1996, 98:600-603.
38. Raymond C.S., Soriano P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2007, 2:e162.
39. Ringrose L.H., Lounas V., Ehrlich L., Buchholz F., Wade R., Stewart A.F. Comparative kinetic analysis of FLP and Cre recombinases: Mathematical models for DNA binding and recombination. J. Mol. Biol. 1998, 284:363-384.
40. Ringrose L., Chabanis S., Angrand P.-O., Woodroofe C., Stewart A.F. Quantitative comparison of DNA looping in vitro and in vivo: Chromatin increases effective DNA flexibility at short distances. EMBO J. 1999, 23:6630-6641.
41. Rodriguez C.I., Buchholz F., Galloway J., Sequerra R., Kasper J., Ayala R., Stewart A.F., Dymecki S.M. High efficiency FLPe deleter mice provide a complement to Cre-loxP for in vivo genetic engineering. Nat. Genet. 2000, 25:139-140.
42. Sauer B., McDermott J. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages. Nucleic Acids Res. 2004, 32:6086-6095.
43. Schaft J., Ashery-Padan R., van der Hoeven F., Gruss P., Stewart A.F. Efficient FLP recombination in mouse ES cells and oocytes. Genesis 2001, 31:6-10.
44. Schlake T., Bode J. Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry 1994, 33:12746-12751.
45. Schmidt E.E., Taylor D.S., Prigge J.R., Barnett S., Capecchi M.R. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc. Natl. Acad. Sci. USA 2000, 97:13702-13707.
46. Schmidt-Supprian M., Rajewsky K. Vagaries of conditional gene targeting. Nat. Immunol. 2007, 8:665-668.
47. Schnütgen F., Doerflinger N., Calléja C., Wendling O., Chambon P., Ghyselinck N.B. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat. Biotechnol. 2003, 21:562-565.
48. Schnütgen F., De-Zolt S., Van Sloun P., Hollatz M., Floss T., Hansen J., Altschmied J., Seisenberger C., Ghyselinck N.B., Ruiz P., Chambon P., Wurst W., von Melchner H. Genomewide production of multipurpose alleles for the functional analysis of the mouse genome. Proc. Natl. Acad. Sci. USA 2005, 102:7221-7226.
49. Schnütgen F., Stewart A.F., von Melchner H., Anastassiadis K. Engineering embryonic stem cells with recombinase systems. Methods Enzymol. 2006, 420:100-136.
50. Schönig K., Schwenk F., Rajewsky K., Bujard H. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res. 2002, 30:e134.
51. Schwenk F., Kühn R., Angrand P.-O., Rajewsky K., Stewart A.F. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 1998, 26:1427-1432.
52. Seibler J., Zevnik B., Küter-Luks B., Andreas S., Kern H., Hennek T., Rode A., Heimann C., Faust N., Kauselmann G., Schoor M., Jaenisch R., et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 2003, 31:e12.
53. Senecoff J.F., Rossmeissl P.J., Cox M.M. DNA recognition by the FLP recombinase of the yeast 2 mu plasmid. A mutational analysis of the FLP binding site. J. Mol. Biol. 1988, 201:405-421.
54. Shimshek D.R., Kim J., Hübner M.R., Spergel D.J., Buchholz F., Casanova E., Stewart A.F., Seeburg P.H., Sprengel R. Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis 2002, 32:19-26.
55. Smith M.C., Thorpe H.M. Diversity in the serine recombinases. Mol. Microbiol. 2002, 44:299-307.
56. Testa G., Zhang Y., Vintersten K., van der Hoeven F., Benes V., Chambers I., Smith A.J.H., Smith A.A., Stewart A.F. Engineering the mouse genome with bacterial artificial chromosomes to create multi-purpose alleles. Nat. Biotechnol. 2003, 21:443-447.
57. Testa G., Schaft J., van der Hoeven F., Glaser S., Anastassiadis K., Zhang Y., Hermann T., Stremmel W., Stewart A.F. A reliable expression reporter cassette for multipurpose, knock-out/conditional mouse alleles. Genesis 2004, 38:151-158.
58. Thomson J.G., Rucker E.B., Piedrahida A. Mutational analysis of loxP sites for efficient Cre-mediated insertion into genomic DNA. Genesis 2003, 36:162-167.
59. van der Weyden L., Shaw-Smith C., Bradley A. Chromosome engineering in ES cells. Methods Mol. Biol. 2009, 530:49-77.
60. van Duyne G.D. A structural view of Cre-loxP site-specific recombination. Annu. Rev. Biophys. Biomol. Struct. 2001, 30:87-104.
61. Vintersten K., Testa G., Naumann R., Anastassiadis K., Stewart A.F. Bacterial artificial chromosome transgenesis through pronuclear injection of fertilized mouse oocytes. Methods. Mol. Biol. 2008, 415:83-100.
62. Wallace H.A., Marques-Kranc F., Richardson M., Luna-Crespo F., Sharpe J.A., Hughes J., Wood W.G., Higgs D.R., Smith A.J. Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence. Cell 2007, 128:197-209.
63. Wu S., Ying G., Wu Q., Capecchi M.R. Toward simpler and faster genome-wide mutagenesis in mice. Nat. Genet. 2007, 39:922-930.
64. Wu Y., Wang C., Sun H., LeRoith D., Yakar S. High-efficient FLPo deleter mice in C57BL/6J background. PLoS ONE 2009, 4:e8054.
65. Yu Y., Bradley A. Engineering chromosomal rearrangements in mice. Nat. Rev. Genet. 2001, 2:780-790.
66. Zhang Y., Buchholz F., Muyrers J.P., Stewart A.F. A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 1998, 20:123-128.